Ischemic Cardiomyopathy
Conditions
Interventions
Bypass surgery and test product administration
Bypass surgery and placebo administration
Sponsors
Osaka University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who are clinically diagnosed with ischemic cardiomyopathy and receive CABG 2) Patients with a left ventricular ejection fraction of 40% or less by cardiac ultrasonography within 4 weeks before obtaining consent 3) Others
Exclusion criteria
Exclusion criteria: 1) Patients who have a combination of cardiovascular disease such as severe organic valvular disease or aortic aneurysm determined by investigator or co-investigator to affect clinical trial procedure 2) Patients whose participation in a clinical trial is considered inappropriate at the discretion of the investigator or co-investigator 3) Others
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Adverse event and safety evaluation related to this product 2) Efficacy(exploratory) 3) Feasibility | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) Cardiac function 2) Exercise tolerance 3) Other | — |
Countries
Japan
Contacts
Public ContactDaisuke MORI
Osaka University Hospital Department of Cardiovascular Surgery
Outcome results
None listed